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Red blood cells (RBCs) generate microvesicles to remove damaged cell constituents
such as oxidized hemoglobin and damaged membrane constituents, and thereby
prolong their lifespan. Damage to hemoglobin, in combination with altered
phosphorylation of membrane proteins such as band 3, lead to a weakening of the
binding between the lipid bilayer and the cytoskeleton, and thereby to membrane
budding and microparticle shedding. Microvesicle generation is disturbed in patients
with RBC-centered diseases, such as sickle cell disease, glucose 6-phosphate
dehydrogenase deficiency, spherocytosis or malaria. A disturbance of the membrane-
cytoskeleton interaction is likely to be the main underlying mechanism, as is supported
by data obtained from RBCs stored in blood bank conditions. A detailed proteomic,
lipidomic and immunogenic comparison of microvesicles derived from different sources
is essential in the identification of the processes that trigger vesicle generation. The
contribution of RBC-derived microvesicles to inflammation, thrombosis and autoimmune
reactions emphasizes the need for a better understanding of the mechanisms and
consequences of microvesicle generation.
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INTRODUCTION
Generation of microvesicles, i.e., extracellular vesicles that are shed from the plasma membrane
(Raposo and Stoorvogel, 2013), constitutes an integral part of red blood cell (RBC) homeostasis,
and is responsible for the loss of 20% of the hemoglobin and the cell membrane during
physiological RBC aging in vivo, and the accompanying decrease in cell volume and increase
in cell density (Willekens et al., 2003, 2008). The blood of healthy subjects contains
approximately 1000 RBC-derived vesicles per microliter of plasma (Berckmans et al., 2001;
Hron et al., 2007; Westerman et al., 2008; Willekens et al., 2008). The microvesicle hemoglobin
composition suggests an enrichment of the irreversibly modified hemoglobins HbA1c and
HbA1e2. Microvesicles contain various immunological recognition and removal signals (Willekens
et al., 2008), that are responsible for a rapid elimination – probably within minutes – from
the circulation (Willekens et al., 2005, 2008). Shedding of damaged cellular components by
vesiculation prevents untimely removal of otherwise functional RBCs, as well as unwanted
reactions of the hemostasis and immune systems. Thus, vesiculation couples general aging
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processes such as oxidation and glycation to organismal
homeostasis. On the other hand, RBC-centered
hemoglobinopathies such as sickle cell disease and thalassemia
are accompanied by a substantial increase in microvesicle levels
(Ferru et al., 2014; Camus et al., 2015). Also, infection of RBC
with the malaria parasite Plasmodium induces vesicle formation.
However, the underlying mechanism is likely to be strongly
influenced by parasite-derived proteins, and therefore beyond
the scope of this review (e.g., Mantel et al., 2013). Increased
vesiculation is associated with systemic inflammation, which
may be directly responsible for hemolysis and anemia (Dinkla
et al., 2012b, 2016). Thus, microvesicles are part of the complex
of interactions between RBCs and the organism (Bosman,
2016a,b). In this review, we aim to integrate the newest data on
microvesicle composition and production in various conditions,
in order to obtain more insight into the basic mechanisms
underlying microvesicle generation, and the involvement of
RBC-derived microvesicles in pathophysiology.
MICROVESICLES IN VIVO
Immunochemical analyses together with a proteomic inventory
of RBC-derived microvesicles from the plasma of healthy
individuals show the almost exclusive presence of the membrane
proteins band 3 and actin (Bosman et al., 2012). Microvesicles
are enriched in enzymes involved in redox homeostasis, i.e.,
glutathione S-transferase, thioredoxin and peroxiredoxin-1 and
peroxiredoxin-2, and in ubiquitin. The hemoglobin composition
of microvesicles isolated from plasma resembles that of the oldest
cells, with an enrichment in irreversibly modified hemoglobins
HbA1c and HbA1e2 (Willekens et al., 1997). Microvesicles
display removal signals such as phosphatidylserine in the outer
membrane layer and senescent cell-specific band 3 epitopes that
are mainly found in the oldest RBCs (Willekens et al., 2008).
Also, microvesicles contain the glycosylphosphatidylinositol
(GPI)-anchored, complement-inhibiting proteins CD55 and
CD59. These may not be in a functional configuration,
as recently shown for the, similarly GPI-anchored enzyme
acetylcholinesterase (Willekens et al., 2008; Freitas Leal et al.,
2017). The striking absence of spectrin and ankyrin in
microvesicles, together with immunoblot and proteomic patterns
indicating extensive protein degradation in the oldest RBCs,
as well as the aging-related increase in membrane-associated
proteasome components (Bosman et al., 2012), all support
a role for proteolytic breakdown of the band 3-ankyrin
connection between the cytoskeleton and the lipid bilayer in the
vesiculation process. However, the absence of especially spectrin
in microvesicles isolated from the blood has led to alternative
explanations for the aging-associated changes in RBC cell volume
and density (Ciana et al., 2017a,b). The breakage of the band
3-ankyrin binding is predicted to cause a relaxation of the
cytoskeletal spring and thereby spontaneous buckling of the lipid
bilayer, resulting in evagination and vesiculation (Sens and Gov,
2007; Bosman et al., 2012) (Figure 1). Proteomic analysis of aging
RBCs and RBC-derived microvesicles purified from the plasma
support this model (Bosman et al., 2012), but do not provide
many clues for the upstream processes, or for the relatively high
concentration of actin in the microvesicles. The hemoglobin
data, together with the accumulation of redox status-regulating
enzymes, indicate that damage to hemoglobin may be such an
upstream process, if not the primary trigger for vesiculation.
A role for damaged hemoglobin in vesiculation is supported by
the finding that the concentration of RBC-derived microvesicles
is increased in the blood of patients with hemoglobinopathies
(Westerman et al., 2008). The microvesicles from the blood of
thalassemia patients contain high concentrations of oxidized,
denatured alpha globin chains (Ferru et al., 2014). Also, these
microvesicles contain enzymes involved in the maintenance of
redox status such as catalase and peroxiredoxin-2, as well as large
amounts of complement proteins and immunoglobulins (Ferru
et al., 2014).
The protein composition of microvesicles from patients with
membranopathies, i.e., abnormal RBCs such as elliptocytes
and stomatocytes due to genetic aberrations in membrane
proteins, is likely to differ from those of control RBCs.
Actual data are lacking, but this prediction can be deduced
from the effects of splenectomy on the membrane protein
composition of spectrin/ankyrin-deficient and band 3-deficient
spherocytes (Reliene et al., 2002; Alaarg et al., 2013). In
RBCs from patients with thalassemia intermedia, hemoglobin
damage may induce the formation of band 3 polymers,
associated with increased phosphorylation that leads to a
weakening of the band 3-ankyrin connection, resulting in
microvesicle formation (Ferru et al., 2014). These observations,
together with the vesiculation-reducing effect of p72Syk kinase
inhibitors, not only support a central role for the binding of
modified hemoglobin, possibly especially to oxidized and/or
proteolytically degraded band 3 (Arashiki et al., 2013; Lange
et al., 2014) in the vesiculation process (Figure 1), but also
show the involvement of phosphorylation networks in RBC
homeostasis. The involvement of various signaling pathways in
RBC vesiculation was supported by the relative large numbers of
signaling proteins in microvesicles obtained from the plasma of
a healthy donor (Bosman et al., 2012), and in a pharmacological
screening in vitro (Kostova et al., 2015).
THE INVOLVEMENT OF MICROVESICLES
IN COAGULATION AND INFLAMMATION
Most RBC-derived microvesicles from healthy donors as well
as from various patients expose phosphatidylserine, which
promotes not only phagocytosis but also coagulation.
In vitro, thrombin generation through the intrinsic pathway
has been shown to be induced by RBC-derived microvesicles
derived from sickle cell patients, storage units, or after treatment
with a calcium ionophore (van Beers et al., 2009; van der Meijden
et al., 2012; Rubin et al., 2013). In addition, correlations have been
reported between the number of phosphatidylserine-exposing,
RBC-derived microvesicles, and thrombin generation in sickle
cell patients (van Beers et al., 2009; Gerotziafas et al., 2012).
Microvesicles may also disturb anticoagulation reactions of the
protein C system, possibly through binding of protein S (e.g.,
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Koshiar et al., 2014). Increases in RBC-derived microvesicles in
sickle cell disease and thalassemia patients is often accompanied
by a decrease in deformability and hemolysis, which may as such
constitute a risk factor for thrombosis.
Phagocytosis-triggered monocyte activation may induce
proinflammatory and procoagulant endothelial cell responses
(Straat et al., 2016). Thrombin may promote inflammation
by activation of the complement system, e.g., by acting as
C3 or C5 convertase (Zecher et al., 2014). RBCs of patients
with paroxysmal nocturnal hemoglobinuria (PNH) lack the
GPI-anchored proteins CD55 and CD59 that protect against
complement activation-associated hemolysis. GPI-anchored
proteins may be involved in raft formation (Salzer and Prohaska,
2001), and their absence may be directly responsible for the
release of relatively high numbers of RBC-derived microvesicles
with procoagulant activity in PNH patients in vitro (Hugel et al.,
1999; Kozuma et al., 2011; Devalet et al., 2014). In addition,
microvesicles scavenge NO almost as fast as free hemoglobin
and much faster than RBCs, which may impair vasodilation
(Donadee et al., 2011). This effect is already detectable with the
number of microvesicles present in one transfusion unit (Liu
et al., 2013).
THE ROLE OF THE SPLEEN
The spleen facilitates vesiculation, as apparent from the
retention of microvesicles in RBCs in asplenic individuals.
In these individuals, the normal aging-related decrease in
total RBC hemoglobin is absent, due to an increase in
HbA1c (Willekens et al., 2003). In patients with spherocytosis,
splenectomy increased RBC deformability in vitro, probably
by inhibiting spleen-mediated microvesicle shedding (Reliene
et al., 2002). The molecular mechanism underlying vesiculation
in the spleen is unknown, but may involve a combination of
biochemical and biophysical stress. Recent model simulations
support the involvement of degraded hemoglobin in reducing
the cytoskeleton/membrane connection, thereby promoting
microvesicle shedding during splenic flow (Zhu et al., 2017).
Thus, the mechanical and biochemical circumstances in the
spleen, together with the presence of specialized macrophages,
may make the spleen a microvesicle-based quality control and
repair system. This emphasizes the importance of establishing
the functionality of the spleen, especially in the study of
diabetic control (Willekens et al., 2003). Also, the notable
paucity of data for microvesicles generated in vivo warrants
a more detailed investigation on the fundamental and clinical
relationship between splenectomy or functional asplenia, RBC-
derived microvesicles and RBC homeostasis (Wernick et al.,
2017).
MICROVESICLES IN VITRO
Vesiculation also occurs during storage of RBCs in the blood
bank. Storage microvesicles contain removal signals such as
phosphatidylserine in the outer layer of their membrane and
degraded as well as aggregated band 3 molecules, similar to
microvesicles in the circulation (Bosman et al., 2008; Willekens
et al., 2008). In blood bank microvesicles, the number of carbonyl
groups is increased relative to RBC membranes, possibly due
to the accumulation of oxidized membrane proteins band 3,
actin and protein 4.1 (Bosman et al., 2008; Kriebardis et al.,
2008; Delobel et al., 2016). This is accompanied by a correlation
between oxidized cell constituents and vesiculation during
storage (D’Alessandro et al., 2017). Blood bank microvesicles
are immunologically active, as they contain immunoglobulins
and complement factors, derived from the plasma fraction
of the storage fluid (Bosman et al., 2008; Kriebardis et al.,
2008). Also, storage microvesicles are readily recognized by
pathological autoantibodies from patients with autoimmune
hemolytic anemia (Dinkla et al., 2012a). These data indicate that
the coupling of removal of damaged components from the RBC
to their removal from the circulation is a general phenomenon for
RBC-derived microvesicles. The enrichment of the GPI-anchored
proteins acetylcholinesterase and CD55, as well as raft-associated
forms of stomatin and the flotillins in storage microvesicles,
indicates that lipid-related changes in membrane organization
are involved in vesiculation during storage (Bosman et al., 2008;
Salzer et al., 2008). The underlying mechanism has been proposed
to be revolving around membrane budding and fission. This
could be triggered by the loss of binding between cytoskeletal and
membrane proteins, followed by large-scale separation of various
lipid phases that may be formed by membrane protein-stabilized
microdomains (Salzer et al., 2008). The loss of interaction
between the cytoskeleton and cell membrane may be triggered
by oxidized hemoglobin, similar to what may happen in vivo.
Indeed, accumulation of oxidized hemoglobin residues during
storage is accompanied by their enrichment in microvesicles
(Wither et al., 2016). This role of hemoglobin in microvesicle
formation is supported by the observation that, in the early phase
of storage, a significant amount of hemoglobin is associated with
the lipid bilayer in microvesicles (Szigyártó et al., 2018). There
is a shortage of detailed quantitative and qualitative information
on the primary triggers driving microvesicle production in vitro.
The available data, albeit mostly showing associations, support
a role of phosphorylation and rearrangement of band 3. For
example, inhibition of tyrosine dephosphorylation not only
induces RBC shapes such as echinocytes, which indicates a loss
of interaction between the cytoskeleton and the lipid bilayer but
also stimulates microvesicle production in vitro (Ferru et al.,
2011, 2014; Cluitmans et al., 2016). In the misshapen cells found
in patients with neuroacanthocytosis, disturbed phosphorylation
and altered cell morphology are accompanied by disturbed
microvesicle generation (Bosman and De Franceschi, 2008).
Phosphorylation of band 3 is associated with clustering and
correlates with microvesicle formation during storage and in
the RBCs of patients with thalassemia intermedia (Ferru et al.,
2014; Azouzi et al., 2018). Similar effects are observed upon
treatment of RBCs with agents that induce aggregation of band
3 (Ferru et al., 2011; Cluitmans et al., 2016). A well-known
stimulus for microvesicle formation in vitro is an artificial
increase in intracellular calcium concentration. However, the
protein composition of calcium-induced microvesicles differs
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FIGURE 1 | Vesiculation in progress. Structure of the RBC membrane during vesiculation, showing mechanisms involved in microvesicle shedding: breakdown of
the cytoskeleton by calcium-dependent proteases; lipid bilayer rearrangement due to altered phospholipid transporter activities, which results in phosphatidylserine
exposure; changes in band 3 configuration and distribution due to oxidation, binding of damaged hemoglobin, and phosphorylation, leading to loss of binding to the
cytoskeleton at the ankyrin complex, recognition by IgG, and vesiculation. The order and interdependence of these processes are discussed in the text. PC,
phosphatidylcholine; SM, sphingomyelin; PS, phosphatidylserine; PE, phosphatidylethanolamine.
from storage or blood microvesicles, e.g., the content of
membrane proteins, the presence of band 3 aggregates and
breakdown products, and of raft-associated proteins (Bosman
et al., 2008; Salzer et al., 2008; Prudent et al., 2015). This indicates
that alterations in intracellular calcium concentrations are not
primary factors in microvesicle generation in vivo, nor in the
blood bank.
MECHANISMS OF VESICULATION:
INVOLVEMENT OF LIPIDS
The few data that are available indicate that disturbances
of the organization of the lipid part of the cell membrane
may play a role in the vesiculation process. The RBC
membrane contains sphingomyelin/cholesterol-enriched as well
as cholesterol-enriched domains that are associated with high-
curvature areas. Since these domains become associated with
budding membrane areas during storage at 4◦C, they have
been speculated to be specific sites of microvesicle generation
(Leonard et al., 2017). However, RBCs and microvesicles
obtained during storage in blood bank conditions showed
no significant differences in the main phospholipid classes
(Laurén et al., 2018). This included the lack of enrichment
of the raft-associated lipids cholesterol and sphingomyelin.
Thus, lipid-involving reorganizations in the RBC membrane
may be instrumental in microvesicle generation, but they do
not seem to result in significant alterations in microvesicle
lipid composition. Changes in membrane lipid organization,
such as an increase in exposure of phosphatidylserine and/or
phosphatidylethanolamine, may promote vesiculation during
storage (Verhoeven et al., 2006; Larson et al., 2017). However,
severe disruptions of the protein-protein interactions, that are
associated with altered RBC morphology, may induce increased
microvesicle generation, but are not always accompanied by
increased phosphatidylserine exposure (Cluitmans et al., 2016)
(Figure 1). In this context, it should be emphasized that not
all RBC-derived microvesicles expose detectable amounts of
phosphatidylserine (Willekens et al., 2008; Nielsen et al., 2014).
Disruption of the lipid bilayer, e.g., by treating RBCs with
sphingomyelinase, strongly catalysed microvesicle generation
in vitro. This process was accompanied by the appearance
of CD59 and stomatin clusters in the RBCs, supporting
a role for lipid rearrangement in microvesicle formation.
The sphingomyelinase-induced microvesicles were much more
heterogeneous in phosphatidylserine exposure and glycophorin
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A content than the microvesicles generated by spontaneous
vesiculation, indicating the involvement of different mechanisms
(Dinkla et al., 2012b). Thus, changes in lipid organization may
facilitate microvesicle formation, but may not constitute the
primary mechanism in most physiological conditions.
MECHANISMS OF VESICULATION:
COMPARISON WITH EXOSOME
FORMATION
All reports on RBC-derived microvesicle composition, especially
in combination with the aging-associated changes in the RBC
membrane proteome, indicate the involvement of proteins that
are involved in the release of exosomes as well (Raposo and
Stoorvogel, 2013). This includes small GTPases, lipid raft-
associated proteins such as acetylcholinesterase and flotillins, and
annexins (Bosman et al., 2012; Raposo and Stoorvogel, 2013;
Prudent et al., 2015). Although it is not clear how cytosolic
components end up in exosomes, the mechanisms by which
cytosolic molecules are recruited into RBC-derived microvesicles
may be similar to those involved in exosome generation, as
indicated by the presence of various chaperone proteins (Bosman
et al., 2012; Raposo and Stoorvogel, 2013). The molecular details
of the mechanisms underlying microvesicle generation in other
cell types are largely unknown. Incorporation of the available
data on RBC-derived microvesicles into the catalog ‘Vesiclepedia’
(Kalra et al., 2012) may be a worthwhile first step toward further
elucidation of the mechanism of microvesicle in RBCs, as well
as in other cell types. A comparison of RBC microvesicle data
with the already available data on RBC exosomes that are shed
by reticulocytes from human cord blood (Chu et al., 2018) will
facilitate the identification of the molecular mechanisms involved
in various types of vesiculation in vivo. Already, endocytosis and
autophagy have been involved in the disappearance of CD71
and other membrane proteins during reticulocyte maturation
in vitro (Griffiths et al., 2012). Such an approach profits from
the possibility that RBCs create to study exosome as well as
microvesicle formation during differentiation and aging in the
same cell, that has a relatively homogeneous and well-charted
membrane system.
FROM MECHANISM TO MARKER TO
MEDICINE
Red blood cells form microvesicles in response to a variety of
physiological and pathological triggers. Although the inventory
of the composition of microvesicles generated in different
circumstances is far from complete, the available data indicate
that they all are enriched in damaged RBC components,
depending on the various stimuli (Figure 1). This suggests that an
exhaustive study of RBC-derived microvesicles will offer insights
into the molecular mechanisms of their generation in vivo,
and thereby into the physiological and pathological triggers.
Also, RBC-derived microvesicles may constitute a model for
the study of the biological, biophysical and clinical properties
of microvesicles in general. This model will benefit from the
comparison of the composition and characteristics of RBC-
derived microvesicles with microvesicles generated by other
cell types, and with exosomes. RBC-derived microvesicles are
potentially sensitive and specific biomarkers for the clinical
severity of RBC-centered diseases such as sickle cell disease,
thalassemia or spherocytosis (Reliene et al., 2002; Hebbel
and Key, 2016; Kittivorapart et al., 2018). Also, microvesicles
may reveal the activity as well as the clinical consequences,
such as anemia or thrombosis, of systemic processes, such as
inflammation. In addition, RBC-derived microvesicles may be
useful in the transfer of surface proteins, as has been shown in
the ‘painting’ of RBCs of PNH patients with the complement-
protecting proteins CD55 and CD59 (Sloand et al., 2004).
Where RBC-derived microvesicles may be actively involved
in pathology, e.g., by their procoagulant, proinflammatory or
autoimmune activity (Sadallah et al., 2008), pharmacological
prevention of the formation of harmful microvesicles may
become of clinical importance. The recent finding that inhibition
of sphingomyelinase attenuated lung inflammation caused by
infusion of stored RBC-derived microvesicles (Hoehn et al.,
2017), supports this notion. Thus, on one hand, microvesicle
shedding may prevent the untimely removal of functional RBCs
in physiological conditions. On the other hand, in pathological
conditions, prevention of vesiculation following splenectomy
may have beneficial effects, or prevent a pathological immune
reaction, for example after massive or frequent RBC transfusion
in compromised, transfusion-dependent patients.
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